BR112018001207A2 - novo peptídeo e uso do mesmo - Google Patents

novo peptídeo e uso do mesmo

Info

Publication number
BR112018001207A2
BR112018001207A2 BR112018001207A BR112018001207A BR112018001207A2 BR 112018001207 A2 BR112018001207 A2 BR 112018001207A2 BR 112018001207 A BR112018001207 A BR 112018001207A BR 112018001207 A BR112018001207 A BR 112018001207A BR 112018001207 A2 BR112018001207 A2 BR 112018001207A2
Authority
BR
Brazil
Prior art keywords
new peptide
sequence
cancer
treated
pharmaceutically acceptable
Prior art date
Application number
BR112018001207A
Other languages
English (en)
Inventor
Soon Hwang Duk
Joung Moon Eun
Jin Kim Hae
Original Assignee
Ensol Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ensol Biosciences Inc filed Critical Ensol Biosciences Inc
Publication of BR112018001207A2 publication Critical patent/BR112018001207A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

esta invenção se refere a um peptídeo que consiste em uma sequência de aminoácidos de seq id no: 1 ou um sal farmaceuticamente aceitável do mesmo, e ao uso do mesmo. de acordo com esta invenção, o câncer pode ser eficazmente prevenido ou tratado.
BR112018001207A 2015-07-23 2016-07-22 novo peptídeo e uso do mesmo BR112018001207A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020150104332A KR101644982B1 (ko) 2015-07-23 2015-07-23 신규 펩타이드 및 그 용도
PCT/KR2016/008062 WO2017014604A1 (en) 2015-07-23 2016-07-22 Novel peptide and use thereof

Publications (1)

Publication Number Publication Date
BR112018001207A2 true BR112018001207A2 (pt) 2018-09-25

Family

ID=56708394

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018001207A BR112018001207A2 (pt) 2015-07-23 2016-07-22 novo peptídeo e uso do mesmo

Country Status (10)

Country Link
US (1) US10189875B2 (pt)
EP (1) EP3325499A4 (pt)
JP (1) JP6484839B2 (pt)
KR (1) KR101644982B1 (pt)
CN (1) CN107787325B (pt)
AU (1) AU2016297311B2 (pt)
BR (1) BR112018001207A2 (pt)
CA (1) CA2992971C (pt)
RU (1) RU2693478C1 (pt)
WO (1) WO2017014604A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101995768B1 (ko) * 2019-03-13 2019-07-03 (주)엔솔바이오사이언스 신규 펩타이드 및 그 용도
KR102417762B1 (ko) * 2021-11-17 2022-07-06 주식회사 엔솔바이오사이언스 펜타펩타이드 및 그 용도

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039662A (en) * 1989-05-10 1991-08-13 Monsanto Peptide with anti-metastasis activity
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
US6451969B1 (en) * 1999-01-15 2002-09-17 The Burnham Institute Methods for inhibiting tumor metastasis, and peptides useful therfor
ITRM20030386A1 (it) * 2003-08-05 2005-02-06 Istituto Naz Per Le Malattie Infettive Lazz Metodo e test diagnostici basati sull'analisi citofluorimetrica dei linfociti t antigene-specifici.
JP2008528635A (ja) * 2005-02-01 2008-07-31 アテニュオン，エルエルシー Ａｃ−ＰＨＳＣＮ−ＮＨ２の酸付加塩
KR100794499B1 (ko) 2006-05-16 2008-01-16 주식회사 프로메디텍 개구린 ５로부터 합성 및 제조된 항생 및 항암 신규펩타이드 유도체
KR101061017B1 (ko) * 2009-10-23 2011-08-31 (주) 수파드엘릭사 암세포의 성장 및/또는 전이 억제용 약학 조성물
KR101029705B1 (ko) * 2010-06-30 2011-04-18 (주)엔솔테크 신규 펩타이드 및 그 용도
KR101500670B1 (ko) * 2010-11-02 2015-03-10 인하대학교 산학협력단 암전이를 억제하는 항원 펩타이드, 이를 포함하는 암전이 백신, 암전이 억제 및 치료용 조성물 그리고 암전이 관련 표적물질 및 암전이 억제물질의 스크린 방법
DE112012000404T5 (de) * 2011-01-04 2014-04-17 Charitè Universitätsmedizin Berlin Modulatoren von IL-12 und/oder IL-23 zur Prävention oder Behandlung des Morbus Alzheimer
AU2013202137B2 (en) * 2012-01-24 2015-09-10 Inter-K Pty Limited Peptide agents for cancer therapy
JP6078844B2 (ja) * 2012-09-26 2017-02-15 公立大学法人大阪市立大学 癌免疫療法のためのペプチド及びその利用
KR102067613B1 (ko) * 2013-03-28 2020-01-20 삼성전자주식회사 항 c-Met 항체 및 항 her2 항체를 포함하는 병용 투여용 조성물
KR101467676B1 (ko) * 2013-04-12 2014-12-04 울산대학교 산학협력단 암 표적용 펩타이드 및 이의 의학적 용도

Also Published As

Publication number Publication date
EP3325499A1 (en) 2018-05-30
EP3325499A4 (en) 2018-12-26
JP6484839B2 (ja) 2019-03-20
CN107787325A (zh) 2018-03-09
AU2016297311B2 (en) 2018-12-06
CN107787325B (zh) 2021-09-10
RU2693478C1 (ru) 2019-07-03
JP2018520131A (ja) 2018-07-26
AU2016297311A1 (en) 2018-01-18
CA2992971A1 (en) 2017-01-26
US20180186834A1 (en) 2018-07-05
US10189875B2 (en) 2019-01-29
CA2992971C (en) 2020-01-21
WO2017014604A1 (en) 2017-01-26
KR101644982B1 (ko) 2016-08-02

Similar Documents

Publication Publication Date Title
MX2017004488A (es) Composiciones farmaceuticas que comprenden variantes peptidicos y metodos para su uso.
PE20240015A1 (es) Proteinas de fusion gdf15 y usos de estas
CL2016001405A1 (es) A peptide mixture
EP3936141A3 (en) Anti-senescence compounds and uses thereof
EA201990298A1 (ru) Способы и композиции для лечения рака
MX2013007872A (es) Proteina de fusion anticancer.
AR120721A2 (es) Péptidos y composiciones para el tratamiento de daño articular
MX2019008949A (es) Agente terapeutico para cardiomiopatia, infarto al miocardio antiguo e insuficiencia cardiaca cronica.
JOP20200323A1 (ar) طرق لتصنيع تركيبات الأحماض الأمينية
MX2019006943A (es) Polipéptidos para manejo de infecciones virales.
MX2017006748A (es) Composiciones de aminoácidos para el tratamiento de síntomas de enfermedades.
BR112018070819A2 (pt) peptídeos e composições farmacêuticas, nutracêuticas ou veterinárias para prevenção e/ou tratamento de queda de cabelo
PH12021550122A1 (en) Solubilized apyrases, methods and use
EP4219715A3 (en) Stabilized cebpa sarna compositions and methods of use
BR112017014737A2 (pt) formulação de peptídeos inibidores de mk2
BR112017006969A2 (pt) peptídeo derivado de hsp70, composição farmacêutica para o tratamento ou a prevenção de câncer usando o mesmo, indutor de imunidade e método de produção de célula apresentadora de antígeno
BR112018001207A2 (pt) novo peptídeo e uso do mesmo
MX362058B (es) Péptido pntx(19) sintético, composición farmacéutica y uso.
BR112018075613A2 (pt) peptídeos para o tratamento de osteoartrite
CU20210061A7 (es) Composición vacunal que comprende el dominio alfa 3 de mica/b para el tratamiento del cáncer
PH12021550090A1 (en) Composition comprising glycyrrhizin and cosmetic and pharmaceutical uses thereof
MX2017003949A (es) Derivados peptidicos novedosos y sus usos.
MX365952B (es) Composiciones para la prevención y/o el tratamiento de patologías relacionadas con alfa-glucosidasa.
PH12017550079A1 (en) Composition for improving memory, learning ability and cognition
BR112018001542A2 (pt) indutor da imunidade, polipeptídeo possuindo uma atividade indutora da imunidade, célula apresentadora de antígeno isolada e célula t isolada

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]